ProCE Banner Activity

Getting up to Speed With β-Thalassemia: Where We Are Today

Clinical Thought

Are you up to date on the current optimal management of β-thalassemia?

Released: October 15, 2019

Expiration: October 13, 2020

Share

Faculty

Sujit Sheth

Sujit Sheth, MD

Professor
Department of Pediatrics
Weill Cornell Medicine
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Celgene

Faculty Disclosure

Primary Author

Sujit Sheth, MD

Professor
Department of Pediatrics
Weill Cornell Medicine
New York, New York

Sujit Sheth, MD, has disclosed that he has received clinical trial support from ApoPharma, Celgene, La Jolla, Novartis, and Terumo; consulting fees from Acceleron, Celgene, and bluebird bio; and serves on a clinical trial steering committee for CRISPR Therapeutics/Vertex Pharmaceuticals.